| Literature DB >> 33681053 |
Pedram Fadavi1, Helaleh Khoshbakht Ahmadi1, Ali Asghar Yousefi Diba1, Fatemeh Jafari2,3, Mahboobeh Alamolhoda1.
Abstract
BACKGROUND: Irradiation of the adjacent critical structures is inevitable in breast cancer radiotherapy (RT). Our purpose is to assess the dose distribution across the breast tissue and adjacent organs with our institutional asymmetric technique for left-sided breast cancer compared to the standard tangential wedged beam (TWB) and electron-boosted TWB techniques.Entities:
Keywords: Asymmetric therapy; breast cancer; tangential wedged beam
Year: 2020 PMID: 33681053 PMCID: PMC7928138 DOI: 10.4103/jfmpc.jfmpc_1476_20
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
The mean±standard deviation volume (cm3) for target volumes and endangered organs
| TWB | Electron-boosted TWB | Asymmetric | ||
|---|---|---|---|---|
| PTV | 708.19±307.5 (314-1767) | 708.17±307.5 (314-1767) | 685.27±325.4 (115-1767) | >0.05 |
| Heart | 565.34±160.46 (17-913) | 586.63±123.26 (342-913) | 586.65±123.27 (342-913) | >0.05 |
| LAD coronary artery | 4.73±2.55 (1-12) | 4.71±2.57 (1-12) | 4.66±2.64 (1-12) | >0.05 |
| Ipsilateral lung | 1023.2±210.93 (570-1555) | 1025.77±212.34 (570-1555) | 1023.07±210.76 (570-1555) | >0.05 |
PTV: Planning target volume, TWB: Tangential wedged beam, LAD: Left anterior descending
Therapy planning data for the planning target volume and endangered organs
| TWB | Electron-boosted TWB | Asymmetric | ||
|---|---|---|---|---|
| PTV | ||||
| Mean (%) | 102±1.44 | 103.57±3.67 | 101.6±1.8 | >0.05 |
| Maximum (%) | 109.64±2.8 | 117.5±5.96 | 108.96±2.84 | <0.0001# |
| V50 (%) | 69.84±11.97 | 67.87±16.72 | 69.33±12.33 | >0.05 |
| V47.5 (%) | 93.9±3.4 | 91.97±8.83 | 92.43±5.1 | >0.05 |
| V45 (%) | 98.41±1.34 | 97.50±2.63 | 97.18±1.84 | 0.001* |
| Heart | ||||
| Mean (%) | 15.65±5.43 | 11±5.5 | 23.2022.54 | <0.0001# |
| Maximum (%) | 96.13±4.7 | 66.98±26.32 | 89.53±8.18 | <0.0001*,# |
| V25 (%) | 14.82±6.3 | 6.73±5.8 | 12.93±5.7 | 0.004*, <0.0001# |
| LAD coronary artery | ||||
| Mean (%) | 60.55±16.05 | 37.04±21.9 | 55.21±18.7 | 0.3*, <0.0001# |
| Maximum (%) | 99.13±9.32 | 79.8±30.84 | 96.85±7.17 | 0.003# |
| V25 (%) | 57.33±18.77 | 45.9±90.6 | 57.14±19.43 | >0.05 |
| Ipsilateral lung | ||||
| Mean (%) | 27.88±5.92 | 25.53±7.6 | 25.85±5.97 | 0.001* |
| Maximum (%) | 99.71±3.5 | 97.63±5.04 | 97.77±4.22 | 0.01* |
| V20 (%) | 27.32±6.3 | 24.4±8.3 | 26.28±6.5 | >0.05 |
| CLD of medial field (mm) | 37.47±5.6 | 27.67±3.8 | 18.03±4.5 | <0.0001*,# |
*Significant difference between asymmetric technique and TWB, #Significant difference between asymmetric technique and electron-boosted TWB. Data are represented as mean±SD. SD: Standard deviation, PTV: Planning target volume, TWB: Tangential wedged beam, LAD: Left anterior descending, CLD: Central lung distance
Figure 1Histograms indicating the dose versus volume for the heart
Figure 4Histograms indicating the dose versus volume for the planning target volume